No records
|
85 |
Wiguna T., Minayati K., Kaligis F., Ismail R.I., Wijaya E., Murtani B.J., Pradana K. |
24367785700;57218681686;36604651700;55996895500;57358945000;57216652176;57220165625; |
The Effect of Cyberbullying, Abuse, and Screen Time on Non-suicidal Self-Injury Among Adolescents During the Pandemic: A Perspective From the Mediating Role of Stress |
2021 |
Frontiers in Psychiatry |
12 |
|
743329 |
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120410832&doi=10.3389%2ffpsyt.2021.743329&partnerID=40&md5=721d9aa51662421c0092a11d6eaf48a8 |
Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Faculty of Psychology, Universitas Tarumanegara, Jakarta, Indonesia |
Wiguna, T., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Minayati, K., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Kaligis, F., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Ismail, R.I., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Wijaya, E., Faculty of Psychology, Universitas Tarumanegara, Jakarta, Indonesia; Murtani, B.J., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Pradana, K., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
Adolescence is often a period of turmoil. The COVID-19 pandemic has increased adolescents' difficulty due to mental health consequences that may affect their developmental milestones. This study constructed and empirically tested a theoretical model of three predictive factors (cyberbullying, abuse, and screen time) and stress as the mediating factor in adolescent non-suicidal self-injury (NSSI). Structural equation model (SEM) analysis was applied to investigate stress as a mediating factor in the relationship between adolescent NSSI and cyberbullying, abuse, and screen time. This cross-sectional study used a “crowdsourcing” sample collection method to recruit 464 adolescents aged 11–17 years who were administered a questionnaire comprising scales on cyberbullying, abuse, screen time, stress, and NSSI. All scales had construct reliabilities ranging from 0.759 to 0.958. SEM statistical analysis was performed using Lisrel version 8.8 (Scientific Software International, USA) for Windows (Microsoft Corporation, Redmond, WA, USA). The mean (± SD) age of the cohort was 14.61 ± 1.65 years, and consisted of 66.7% females. Secondary high school was the highest educational background (58%). The study found that cyberbullying and abuse were direct positive predictors (critical t-value for the path > 1.96; p < 0.05) of adolescent NSSI; however, screen time did not have any direct relationship. Furthermore, stress was a significant full mediating factor of screen time and a partial mediating factor of cyberbullying and abuse in the relationship with adolescent NSSI (critical t-value of the path = 5.27; p < 0.05). Cyberbullying, screen time, and abuse with the mediating effect of stress could explain 48% of the variance in adolescent NSSI (R2 = 0.48). Adolescent mental health prevention and promotion programs need to be redesigned during the current COVID-19 pandemic to manage their stress and minimize the mental health consequences of cyberbullying, abuse, and inappropriately increased screen time. Copyright © 2021 Wiguna, Minayati, Kaligis, Ismail, Wijaya, Murtani and Pradana. |
abuse; adolescents; COVID-19; cyberbullying; Indonesia; non-suicidal self-injury; screen time; stress |
abuse; adolescent; Article; automutilation; coronavirus disease 2019; cross-sectional study; cyberbullying; educational status; female; health program; human; male; mental health; pandemic; physiological stress; prediction; questionnaire; screen time |
Frontiers Media S.A. |
16640640 |
|
|
Article |
Q1 |
1363 |
2668 |
|
|
118 |
Sen L.T., Siste K., Hanafi E., Murtani B.J., Christian H., Limawan A.P., Adrian, Siswidiani L.P. |
57219034101;55644113100;56737010600;57216652176;57209266195;57202712511;57216932703;57219029296; |
Insights Into Adolescents' Substance Use in a Low–Middle-Income Country During the COVID-19 Pandemic |
2021 |
Frontiers in Psychiatry |
12 |
|
739698 |
|
|
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118257704&doi=10.3389%2ffpsyt.2021.739698&partnerID=40&md5=9b8aba71c0b6aaab6c7e81012e3c8927 |
Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
Sen, L.T., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Siste, K., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Hanafi, E., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Murtani, B.J., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Christian, H., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Limawan, A.P., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Adrian, Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Siswidiani, L.P., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia—Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
Introduction: The COVID-19 pandemic and its lockdown have been a significant life event for many individuals, particularly adolescents. The immense psychological pressure could drive risky behavior, e.g., substance use, while lockdown might lead to decreased use. This study aimed to observe the change in substance use among adolescents in Indonesia and the moderating variables to consumption during the COVID-19 lockdown period. Methods: This study utilized an online survey from April 28, 2020 to June 30, 2020. The hyperlink was disseminated to school administrators and parenting groups through social media and direct messages. A total of 2,932 adolescents (17.4 ± 2.24 and 78.7% females) submitted valid responses. The survey was comprised of a sociodemographic section, substance use details, and psychometric sections, including the Alcohol Use Disorders Identification Test (AUDIT), Cigarette Dependence Scale 12 (CDS-12), Pittsburgh Sleep Quality Index (PSQI), and Strength and Difficulties Questionnaire (SDQ). Results: Overall, adolescent alcohol use during the pandemic was 5.1%, cigarette smoking was 3.1%, and drug consumption was 0.4%. Over half (53.4%) of alcohol drinkers reported increased drinking, and 33.1% had harmful or dependence-like drinking behavior; in contrast, 44.4% of adolescent smokers disclosed reduced cigarette consumption. Around 37.8% of the drug users indicated increased use. During the pandemic, adolescent alcohol use was associated with higher education [adjusted odds ratio (AOR) = 2.67, 95% confidence interval (CI) 1.02–4.86, p = 0.04], higher AUDIT scores (AOR = 1.33, 95% CI 1.25–1.42, p < 0.001), and very low prosocial behavior (AOR = 2.46, 95% CI 1.52–3.88, p < 0.001). Cigarette smoking was correlated with male sex (AOR = 9.56, 95% CI 5.64–16.62, p < 0.001), age (AOR = 1.40, 95% CI 1.14–1.75, p < 0.001), and higher CDS score (AOR = 1.17, 95% CI 1.13–1.20, p < 0.001). Conclusions: Rates of adolescent substance use were significant, with sizeable proportions reporting higher usage. This appeared to occur predominantly in specific demographics and those with a lower protective psychosocial attribute, i.e., prosocial behavior, during the lockdown. These findings should urge the strengthening of adolescent addiction care during and after the pandemic. © Copyright © 2021 Sen, Siste, Hanafi, Murtani, Christian, Limawan, Adrian and Siswidiani. |
adolescent; alcohol; cigarette; COVID-19; drugs; Indonesia |
adolescent; Alcohol Use Disorders Identification Test; Article; Cigarette Dependence Scale 12; cigarette smoking; controlled study; coronavirus disease 2019; demography; descriptive research; educational status; female; health care survey; human; Indonesia; low income country; major clinical study; male; mental disease assessment; middle income country; online analysis; pandemic; Pittsburgh Sleep Quality Index; prevalence; prosocial behavior; psychometry; sex difference; social media; social status; Strength and Difficulties Questionnaire; substance use |
Frontiers Media S.A. |
16640640 |
|
|
Article |
Q1 |
1363 |
2668 |
|
|
231 |
Farhoudian A., Radfar S.R., Ardabili H.M., Rafei P., Ebrahimi M., Zonoozi A.K., De Jong C.A.J., Vahidi M., Yunesian M., Kouimtsidis C., Arunogiri S., Hansen H., Brady K.T., Potenza M.N., Baldacchino A.M., Ekhtiari H., Abagiu A.O., Abouna F.D.N., Ahmed M.H., Al-Ansari B., Al-Khair F.M.A., Almaqbali M.H., Ambekar A., Arya S., Asebikan V.O., Ayasreh M.A., Basu D., Benmebarek Z., Bhad R., Blaise M., Bonnet N., Brasch J., Broers B., Busse A., Butner J.L., Camilleri M., Campello G., Carra G., Celic I., Chalabianloo F., Chaturvedi A., Cherpitel J.J.E.N., Clark K.J., Cyders M.A., de Bernardis E., Deilamizade A., Derry J.E., Dhagudu N.K., Dolezalova P., Dom G., Dunlop A.J., Elhabiby M.M., Elkholy H., Essien N.F., Farah G.I., Ferri M., Floros G.D., Friedman C., Fuderanan C.H., Gerra G., Ghosh A., Gogia M., Grammatikopoulos I.A., Grandinetti P., Guirguis A., Gutnisky D., Haber P.S., Hassani-Abharian P., Hooshyari Z., Ibrahim I.I.M., Ieong H.F.-H., Indradewi R.N., Iskandar S., Isra T.N., Jain S., James S., Javadi S.M.H., Joe K.H., Jokubonis D., Jovanova A.T., Kamal R.M., Kantchelov A.I., Kathiresan P., Katzman G., Kawale P., Kern A.M., Kessler F.H.P., Kim S.-G.S., Kimball A.M., Kljucevic Z., Kurniasanti K.S., Lev R., Lee H.K., Lengvenyte A., Lev-Ran S., Mabelya G.S., Mahi M.A.E., Maphisa J.M., Maremmani I., Masferrer L., Massah O., McCambridge O., McGovern G.G., Min A.K., Moghanibashi-Mansourieh A., Mora-Rios J., Mudalige I.U.K., Mukherjee D., Munira P.M., Myers B., Menon T. N. J., Narasimha V.L., Ndionuka N., Nejatisafa A.-A., Niaz K., Nizami A.T., Nuijens J.H., Orsolini L., Oum V., Oyemade A.A., Palavra I.R., Pant S.B., Paredes J., Peyron E., Quirós R.A., Qurishi R., Rafiq N.U.Z., Raghavendra Rao R., Ratta-Apha W., Raymond K.-L., Reimer J., Renaldo E., Rezapour T., Robertson J.R., Roncero C., Roub F., Rubenstein E.J., Rupp C.I., Saenz E., Salehi M., Samartzis L., Sarubbo L.B., Segrec N., Shah B., Shen H., Shirasaka T., Shoptaw S., Sintango F.M., Sosa V.A., Subata E., Sztycberg N., Taghizadeh F., Wee Teck J.B.T., Tjagvad C., Torrens M., Twala J.M., Vadivel R., Volpicelli J.R., Weijs J., Wintoniw S.M., Wittayanookulluk A., Wojnar M., Yasir S., Yitayih Y., Zhao M., ISAM Global Survey Consortium (ISAM-GSC) |
25631625900;36019651400;55658200400;57218199674;57218203004;57218205554;55394697400;57203060812;14622058700;6602323007;55912287400;57221996850;7101818468;7006591634;6603786612;26632924600;55021572500;57221605725;57221411272;56996118200;55549232500;57221411355;35749590300;35463222300;57221410006;57221410448;18833291700;57219202850;55789741800;6603894892;15135243700;57189041459;7003868723;57196510693;56816710600;57221410155;56400851700;7003818736;24176502200;26026739900;54936844000;57358665500;57221410761;6504408224;55604104700;56059025100;57221409824;57203836122;6603422138;12768470700;57219674374;26767656700;55086535500;57191041815;57221411550;8871569800;12768168000;57221411410;57210375852;55578764500;36833820900;57205763778;27367905800;55487378900;55496109900;57221411047;7004422180;54892046900;36607951600;57216708013;57193806115;57221410095;37004580200;57221604184;57207211289;57216621884;57207842636;15062725000;57188646762;57221411023;36996943600;24468101500;57023935300;57221410517;55928375400;55031071400;57202970264;57221410531;35420584800;57203155640;57209262171;8913859800;8600274900;57189340754;23019092700;57221410613;57223919852;57200792839;7003948428;6507438528;57044778200;56527137000;57221410507;57221411329;56059054800;6506077151;57214574855;57197364393;57221410358;7202684194;57200567557;56272241600;57221410263;55666521300;57194102646;12144358600;7004198198;55376767200;57217227990;16234058300;57225265059;36114863900;57221411223;57205355338;57221409971;55735687800;57221410341;57358663600;35604346900;56783754400;56000939600;57221410809;56968163500;57205640157;7003524112;57191926633;57221411128;7006106435;26656074800;57226311750;36633076300;57221409908;24476669600;57219874143;57216762422;7005625709;7003465287;57221409902;57221409982;56616079200;57221410011;55802145800;57221409677;57188537200;7006681890;57221411350;57219874702;57209053124;57221410085;57221410695;55151590700;6701757799;57221410275;57204013732;55185317400; |
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic |
2021 |
Frontiers in Psychiatry |
12 |
|
646206 |
|
|
|
6 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85113236018&doi=10.3389%2ffpsyt.2021.646206&partnerID=40&md5=583fc4953970f4d964584bcd9a7d5b02 |
Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Department of Neuroscience and Addiction, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran; Integrated Substance Abuse Programs Department, University of California, Los Angeles, Los Angeles, CA, United States; Psychiatry and Behavioral Sciences Research Center, Faculty of Medicine, Ibn-e-Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Psychology, Faculty of Psychology and Education, University of Tehran, Tehran, Iran; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Behavioral Science Institute, Radboud University, Nijmegen, Netherlands; School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Surrey and Borders Partnership National Health Service Foundation Trust, Leatherhead, United Kingdom; Turning Point, Eastern Health, Box Hill, VIC, Australia; Departments of Anthropology and Psychiatry, New York University, New York, NY, United States; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States; Yale School of Medicine, Connecticut Council on Problem Gambling and Connecticut Mental Health Center, New Haven, CT, United States; Division of Population and Behavior Sciences, Medical School, University of St Andrews, St Andrews, United Kingdom; Laureate Institute for Brain Research, Tulsa, OK, United States; National Institute for Infectious Diseases, Prof. Dr. Matei Bals-Arena OMT Department, Romania; Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Cameroon; Alamal psychiatric hospital, Dubai, United Arab Emirates; Sydney Medical School, University of SydneyNSW, Australia; Al Ahliyya Amman University, Amman, Jordan; Ministry of Health, Muscat, Oman; Department of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; State Drug Dependence Treatment Centre, Institute of Mental Health, Pt BDS University of Health Sciences, India; Department of Psychiatry, College of Medicine, University of Ibadan, Nigeria; Addiction Medicine Clinic, Jordan; Drug De-addiction and Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Addiction Medicine Clinic, Mila, Algeria; Centre medical Marmottan, France; Réseau de Prévention des Addictions (RESPADD), France; Department of Psychiatry and Behavioural Neurosciences, Michael DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Geneva University Hospitals, Switzerland; United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; CUNY School of Medicine, New York, United States; Agenzija Sedqa, Malta; Department of Medicine and Surgery, University Milan-Bicocca, Italy; University Psychiatric Hospital Vrapce-Zagreb, Croatia; Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway; Department of Biochemistry, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India; Addiction Medicine Clinic, Mexico; Addiction Crisis Solutions, United States; Department of Psychology, Indiana University Purdue University-Indianapolis, United States; SerT Lentini, ASP Siracusa, Italy; Rebirth Charity Society NGO, Tehran, Iran; Serenity Vista Addiction Treatment Center, Panama; Department of Psychiatry, ESIC Medical College, Hyderabad, Telangana, India; National Institute of Mental Health, Czech Republic; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Belgium; Drug & Alcohol Clinical Services, Hunter New England Local Health District, Australia; Ain Shams University, Cairo, Egypt; Department of Neurology and Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Centre for Research and Information on Substance Abuse, Nigeria; Addiction Medicine Clinic, Syrian Arab Republic; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Italy; Department of Psychiatry, Aristotle University of Thessaloniki, Greece; Brown University and Lifespan Health System, Providence, RI, United States; Fuderanan Mental Health Clinic, Philippines; Drug De-addiction & Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Georgian Harm Reduction Network, Georgia; Organization Against Drugs, Primary Care Health Center, Veria, Greece; Addictions Services (Ser.D.), Department of Territorial Services, ASL Teramo, Italy; Swansea University Medical School, Institute of Life Sciences 2, Singleton CampusSA2 8PP, United Kingdom; Universidad de Buenos Aires, Argentina; University of Sydney, Australia; Institutes for Cognitive Science Studies (IRICSS), Brain and Cognition Clinic, Tehran, Iran; Tehran University of Medical Sciences, Tehran, Iran; Department of Anesthesiology, Yale University, United States; Drugs Rehabilitation Center, National Narcotics Board of Indonesia, Indonesia; Department of Psychiatry, Universitas Padjadjaran, Bandung, West Java, Indonesia; National Institute of Education, Sri Lanka; Department of Psychiatry, Heritage Institute of Medical Sciences (HIMS), Varanasi, India; Univeristi Malaysia Sabah, Malaysia; Department of Social Work, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran; National Center for Mental Health of Korea, South Korea; Republican Center for Addictive Disorders, Lithuania; Addiction Medicine Clinic, North Macedonia; Naufar Institute, Doha, Qatar; The Kantchelov Clinic, Sofia, Bulgaria; Mount Sinai Medical Center, New York, United States; African Institute for Development Policy, Malawi; Sobriety Centers of New Hampshire, United States; Federal University of Rio Grande do Sul, Brazil; Pusan National University Yangsan Hospital, Department of Neuropsychiatry, Yangsan, South Korea; Chatham House, United States; Institute for Public Health of Split-Dalmatia County, Croatia; Faculty of Medicine, Universitas Indonesia-Ciptomangunkusumo Hospital, Indonesia; Scripps Mercy Hospital, San Diego, United States; Department of Psychiatry, The Catholic University of Korea, Seoul, South Korea; Faculty of Medicine, Institute of Clinical Medicine, Psychiatric Clinic, Vilnius University, Vilnius, Lithuania; Israel Center on Addiction, Netanya, Israel; Community Health Work, Tanzania; Hayat Center for Treatment and Psycho-social Rehabilitation, Khartoum, Sudan; University of Botswana, Botswana; V.P. Dole, Dual Disorder Unit, Santa Chiara University Hospital, University of Pisa, Italy; CAS Girona, Department of Psychology, University of Girona, Spain; Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; Community addiction team, Southern Health and Social Care Trust, United Kingdom; Priority Medical Clinic, Dublin, Ireland; Save the Children International Organization, Burma; Dirección de Investigaciones Epidemiológicas y Sociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, United States; Department of Psychiatry, Faculty of Medicine, Sir John Kotelawala Defence University, Sri Lanka; Centre for Addiction Medicine, NIMHANS, Bangalore, India; Kleopatra Kodric, Irena Nisic, Slovenia; Alcohol Tobacco and Other Drug Research Unit, South African Medical Research Council, South Africa; NIMHANS, Bangalore, India; Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India; Federal Neuropsychiatric Hospital, Calabar, Nigeria; Department of Psychiatry, Psychosomatic Research Center, Tehran University of Medical Sciences, Tehran, Iran; Institute of Psychiatry, WHO Collaborating Center for Mental Health, Pakistan; Brijder Addiction Care, Zaandam, Netherlands; Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy; Koh Kong Provincial Hospital, Cambodia; Kaiser Permanente, United States; Psychiatric hospital Sveti Ivan, Zagreb, Croatia; Department of Psychiatry and mental health, Institute of Medicine, Tribhuvan University, Nepal; Universidad de El Salvador, El Salvador; AddiPsy, Lyon, France; Addiction Medicine Clinic, Costa Rica; Novadic-Kentron Addiction Care Network, Vught, Netherlands; Phoenix Foundation for Research and Development, Pakistan; Barwon Health, Geelong, Australia; Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; University of the Sunshine Coast (USC)QLD, Australia; Center for Interdisciplinary Addiction Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Drugs Rehabilitation Center, National Narcotics Board of Indonesia; Department of Cognitive Psychology, Institute for Cognitive Science Studies, Tehran, Iran; Usher Institute, University of Edinburgh, United Kingdom; Psychiatry Service, University of Salamanca Health Care Complex, Salamanca, Spain; PGIMER, Chandigarh, India; Street Health Centre, Canada; Department of Psychiatry, Psychotherapy, and Psychosomatics, Medical University Innsbruck, Austria; Department of Neurosciences and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Medical School, University of Cyprus, Cyprus; Clínica Psiquiátrica de la Facultad de Medicina, Uruguay; Center for Treatment of Drug addiction, University Psychiatric Clinic, Ljubljana, Slovenia; Department of Psychiatry, Patan Academy of Health Sciences, School of Medicine, Lagankhel, Nepal; Department of Psychiatry, Second Xiangya Hospital, Central South University, China; Department of Psychiatry, Teine Keijinkai Medical Center, Japan; David Geffen School of Medicine at UCLA, Department of Family Medicine, United States; Health Professions Councils of Namibia, Namibia; Addiction Medicine Clinic, Uruguay; Asociasion Programa Andres Argentina, Argentina; Mazandaran University of Medical Sciences, Mazandaran, Iran; MRC/CSO SPHSU, University of Glasgow, United Kingdom; Gladsaxe Substance Use Disorder Treatment Centre, Denmark; Institut de Neuropsiquiatria i Addiccions, IMIM-Hospital del Mar, Medical Research, Barcelona, Spain; NACADA, Kenya; Waikato District Health Board (WDHB, Hamilton, New Zealand; Institute of Addiction Medicine, United States; Jellinek, Amsterdam, Netherlands; Addictions Foundation of Manitoba, Canada; Thanyarak Chiangmai Hospital, Thailand; Medical University of Warsaw, Warsaw, Poland; Jimma University, Ethiopia; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, China |
Farhoudian, A., Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Radfar, S.R., Department of Neuroscience and Addiction, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran, Integrated Substance Abuse Programs Department, University of California, Los Angeles, Los Angeles, CA, United States; Ardabili, H.M., Psychiatry and Behavioral Sciences Research Center, Faculty of Medicine, Ibn-e-Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Rafei, P., Department of Psychology, Faculty of Psychology and Education, University of Tehran, Tehran, Iran, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Ebrahimi, M., Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Zonoozi, A.K., Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; De Jong, C.A.J., Behavioral Science Institute, Radboud University, Nijmegen, Netherlands; Vahidi, M., Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Yunesian, M., School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Kouimtsidis, C., Surrey and Borders Partnership National Health Service Foundation Trust, Leatherhead, United Kingdom; Arunogiri, S., Turning Point, Eastern Health, Box Hill, VIC, Australia; Hansen, H., Departments of Anthropology and Psychiatry, New York University, New York, NY, United States; Brady, K.T., Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States; Potenza, M.N., Yale School of Medicine, Connecticut Council on Problem Gambling and Connecticut Mental Health Center, New Haven, CT, United States; Baldacchino, A.M., Division of Population and Behavior Sciences, Medical School, University of St Andrews, St Andrews, United Kingdom; Ekhtiari, H., Laureate Institute for Brain Research, Tulsa, OK, United States; Abagiu, A.O., National Institute for Infectious Diseases, Prof. Dr. Matei Bals-Arena OMT Department, Romania; Abouna, F.D.N., Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Cameroon; Ahmed, M.H., Alamal psychiatric hospital, Dubai, United Arab Emirates; Al-Ansari, B., Sydney Medical School, University of SydneyNSW, Australia; Al-Khair, F.M.A., Al Ahliyya Amman University, Amman, Jordan; Almaqbali, M.H., Ministry of Health, Muscat, Oman; Ambekar, A., Department of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Arya, S., State Drug Dependence Treatment Centre, Institute of Mental Health, Pt BDS University of Health Sciences, India; Asebikan, V.O., Department of Psychiatry, College of Medicine, University of Ibadan, Nigeria; Ayasreh, M.A., Addiction Medicine Clinic, Jordan; Basu, D., Drug De-addiction and Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Benmebarek, Z., Addiction Medicine Clinic, Mila, Algeria; Bhad, R., Department of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Blaise, M., Centre medical Marmottan, France; Bonnet, N., Réseau de Prévention des Addictions (RESPADD), France; Brasch, J., Department of Psychiatry and Behavioural Neurosciences, Michael DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Broers, B., Geneva University Hospitals, Switzerland; Busse, A., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Butner, J.L., CUNY School of Medicine, New York, United States; Camilleri, M., Agenzija Sedqa, Malta; Campello, G., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Carra, G., Department of Medicine and Surgery, University Milan-Bicocca, Italy; Celic, I., University Psychiatric Hospital Vrapce-Zagreb, Croatia; Chalabianloo, F., Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway; Chaturvedi, A., Department of Biochemistry, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India; Cherpitel, J.J.E.N., Addiction Medicine Clinic, Mexico; Clark, K.J., Addiction Crisis Solutions, United States; Cyders, M.A., Department of Psychology, Indiana University Purdue University-Indianapolis, United States; de Bernardis, E., SerT Lentini, ASP Siracusa, Italy; Deilamizade, A., Rebirth Charity Society NGO, Tehran, Iran; Derry, J.E., Serenity Vista Addiction Treatment Center, Panama; Dhagudu, N.K., Department of Psychiatry, ESIC Medical College, Hyderabad, Telangana, India; Dolezalova, P., National Institute of Mental Health, Czech Republic; Dom, G., Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Belgium; Dunlop, A.J., Drug & Alcohol Clinical Services, Hunter New England Local Health District, Australia; Elhabiby, M.M., Ain Shams University, Cairo, Egypt; Elkholy, H., Department of Neurology and Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Essien, N.F., Centre for Research and Information on Substance Abuse, Nigeria; Farah, G.I., Addiction Medicine Clinic, Syrian Arab Republic; Ferri, M., European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Italy; Floros, G.D., Department of Psychiatry, Aristotle University of Thessaloniki, Greece; Friedman, C., Brown University and Lifespan Health System, Providence, RI, United States; Fuderanan, C.H., Fuderanan Mental Health Clinic, Philippines; Gerra, G., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Ghosh, A., Drug De-addiction & Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Gogia, M., Georgian Harm Reduction Network, Georgia; Grammatikopoulos, I.A., Organization Against Drugs, Primary Care Health Center, Veria, Greece; Grandinetti, P., Addictions Services (Ser.D.), Department of Territorial Services, ASL Teramo, Italy; Guirguis, A., Swansea University Medical School, Institute of Life Sciences 2, Singleton CampusSA2 8PP, United Kingdom; Gutnisky, D., Universidad de Buenos Aires, Argentina; Haber, P.S., University of Sydney, Australia; Hassani-Abharian, P., Institutes for Cognitive Science Studies (IRICSS), Brain and Cognition Clinic, Tehran, Iran; Hooshyari, Z., Tehran University of Medical Sciences, Tehran, Iran; Ibrahim, I.I.M., Ain Shams University, Cairo, Egypt; Ieong, H.F.-H., Department of Anesthesiology, Yale University, United States; Indradewi, R.N., Drugs Rehabilitation Center, National Narcotics Board of Indonesia, Indonesia; Iskandar, S., Department of Psychiatry, Universitas Padjadjaran, Bandung, West Java, Indonesia; Isra, T.N., National Institute of Education, Sri Lanka; Jain, S., Department of Psychiatry, Heritage Institute of Medical Sciences (HIMS), Varanasi, India; James, S., Univeristi Malaysia Sabah, Malaysia; Javadi, S.M.H., Department of Social Work, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran; Joe, K.H., National Center for Mental Health of Korea, South Korea; Jokubonis, D., Republican Center for Addictive Disorders, Lithuania; Jovanova, A.T., Addiction Medicine Clinic, North Macedonia; Kamal, R.M., Naufar Institute, Doha, Qatar; Kantchelov, A.I., The Kantchelov Clinic, Sofia, Bulgaria; Kathiresan, P., Department of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Katzman, G., Mount Sinai Medical Center, New York, United States; Kawale, P., African Institute for Development Policy, Malawi; Kern, A.M., Sobriety Centers of New Hampshire, United States; Kessler, F.H.P., Federal University of Rio Grande do Sul, Brazil; Kim, S.-G.S., Pusan National University Yangsan Hospital, Department of Neuropsychiatry, Yangsan, South Korea; Kimball, A.M., Chatham House, United States; Kljucevic, Z., Institute for Public Health of Split-Dalmatia County, Croatia; Kurniasanti, K.S., Faculty of Medicine, Universitas Indonesia-Ciptomangunkusumo Hospital, Indonesia; Lev, R., Scripps Mercy Hospital, San Diego, United States; Lee, H.K., Department of Psychiatry, The Catholic University of Korea, Seoul, South Korea; Lengvenyte, A., Faculty of Medicine, Institute of Clinical Medicine, Psychiatric Clinic, Vilnius University, Vilnius, Lithuania; Lev-Ran, S., Israel Center on Addiction, Netanya, Israel; Mabelya, G.S., Community Health Work, Tanzania; Mahi, M.A.E., Hayat Center for Treatment and Psycho-social Rehabilitation, Khartoum, Sudan; Maphisa, J.M., University of Botswana, Botswana; Maremmani, I., V.P. Dole, Dual Disorder Unit, Santa Chiara University Hospital, University of Pisa, Italy; Masferrer, L., CAS Girona, Department of Psychology, University of Girona, Spain; Massah, O., Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; McCambridge, O., Community addiction team, Southern Health and Social Care Trust, United Kingdom; McGovern, G.G., Priority Medical Clinic, Dublin, Ireland; Min, A.K., Save the Children International Organization, Burma; Moghanibashi-Mansourieh, A., Department of Social Work, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran; Mora-Rios, J., Dirección de Investigaciones Epidemiológicas y Sociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, United States; Mudalige, I.U.K., Department of Psychiatry, Faculty of Medicine, Sir John Kotelawala Defence University, Sri Lanka; Mukherjee, D., Centre for Addiction Medicine, NIMHANS, Bangalore, India; Munira, P.M., Kleopatra Kodric, Irena Nisic, Slovenia; Myers, B., Alcohol Tobacco and Other Drug Research Unit, South African Medical Research Council, South Africa; Menon T. N., J., NIMHANS, Bangalore, India; Narasimha, V.L., Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India; Ndionuka, N., Federal Neuropsychiatric Hospital, Calabar, Nigeria; Nejatisafa, A.-A., Department of Psychiatry, Psychosomatic Research Center, Tehran University of Medical Sciences, Tehran, Iran; Niaz, K., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Nizami, A.T., Institute of Psychiatry, WHO Collaborating Center for Mental Health, Pakistan; Nuijens, J.H., Brijder Addiction Care, Zaandam, Netherlands; Orsolini, L., Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy; Oum, V., Koh Kong Provincial Hospital, Cambodia; Oyemade, A.A., Kaiser Permanente, United States; Palavra, I.R., Psychiatric hospital Sveti Ivan, Zagreb, Croatia; Pant, S.B., Department of Psychiatry and mental health, Institute of Medicine, Tribhuvan University, Nepal; Paredes, J., Universidad de El Salvador, El Salvador; Peyron, E., AddiPsy, Lyon, France; Quirós, R.A., Addiction Medicine Clinic, Costa Rica; Qurishi, R., Novadic-Kentron Addiction Care Network, Vught, Netherlands; Rafiq, N.U.Z., Phoenix Foundation for Research and Development, Pakistan; Raghavendra Rao, R., Barwon Health, Geelong, Australia; Ratta-Apha, W., Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; Raymond, K.-L., University of the Sunshine Coast (USC)QLD, Australia; Reimer, J., Center for Interdisciplinary Addiction Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Renaldo, E., Drugs Rehabilitation Center, National Narcotics Board of Indonesia; Rezapour, T., Department of Cognitive Psychology, Institute for Cognitive Science Studies, Tehran, Iran; Robertson, J.R., Usher Institute, University of Edinburgh, United Kingdom; Roncero, C., Psychiatry Service, University of Salamanca Health Care Complex, Salamanca, Spain; Roub, F., PGIMER, Chandigarh, India; Rubenstein, E.J., Street Health Centre, Canada; Rupp, C.I., Department of Psychiatry, Psychotherapy, and Psychosomatics, Medical University Innsbruck, Austria; Saenz, E., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Salehi, M., Department of Neurosciences and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Samartzis, L., Medical School, University of Cyprus, Cyprus; Sarubbo, L.B., Clínica Psiquiátrica de la Facultad de Medicina, Uruguay; Segrec, N., Center for Treatment of Drug addiction, University Psychiatric Clinic, Ljubljana, Slovenia; Shah, B., Department of Psychiatry, Patan Academy of Health Sciences, School of Medicine, Lagankhel, Nepal; Shen, H., Department of Psychiatry, Second Xiangya Hospital, Central South University, China; Shirasaka, T., Department of Psychiatry, Teine Keijinkai Medical Center, Japan; Shoptaw, S., David Geffen School of Medicine at UCLA, Department of Family Medicine, United States; Sintango, F.M., Health Professions Councils of Namibia, Namibia; Sosa, V.A., Addiction Medicine Clinic, Uruguay; Subata, E., Republican Center for Addictive Disorders, Lithuania; Sztycberg, N., Asociasion Programa Andres Argentina, Argentina; Taghizadeh, F., Mazandaran University of Medical Sciences, Mazandaran, Iran; Wee Teck, J.B.T., MRC/CSO SPHSU, University of Glasgow, United Kingdom; Tjagvad, C., Gladsaxe Substance Use Disorder Treatment Centre, Denmark; Torrens, M., Institut de Neuropsiquiatria i Addiccions, IMIM-Hospital del Mar, Medical Research, Barcelona, Spain; Twala, J.M., NACADA, Kenya; Vadivel, R., Waikato District Health Board (WDHB, Hamilton, New Zealand; Volpicelli, J.R., Institute of Addiction Medicine, United States; Weijs, J., Jellinek, Amsterdam, Netherlands; Wintoniw, S.M., Addictions Foundation of Manitoba, Canada; Wittayanookulluk, A., Thanyarak Chiangmai Hospital, Thailand; Wojnar, M., Medical University of Warsaw, Warsaw, Poland; Yasir, S., Institute of Psychiatry, WHO Collaborating Center for Mental Health, Pakistan; Yitayih, Y., Jimma University, Ethiopia; Zhao, M., Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, China; ISAM Global Survey Consortium (ISAM-GSC) |
Background and Aims: COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing, and “lockdown” measures have affected drug and alcohol supply chains and subsequently their availability, price, and use patterns, with possible downstream effects on presentations of SUDs and demand for treatment. Given the lack of multicentric epidemiologic studies, we conducted a rapid global survey within the International Society of Addiction Medicine (ISAM) network in order to understand the status of substance-use patterns during the current pandemic. Design: Cross-sectional survey. Setting: Worldwide. Participants: Starting on April 4, 2020 during a 5-week period, the survey received 185 responses from 77 countries. Measurements: To assess addiction medicine professionals' perceived changes in drug and alcohol supply, price, use pattern, and related complications during the COVID-19 pandemic. Findings: Participants reported (among who answered “decreased” or “increased”) a decrease in drug supply (69.0%) and at the same time an increase in price (95.3%) globally. With respect to changes in use patterns, an increase in alcohol (71.7%), cannabis (63.0%), prescription opioids (70.9%), and sedative/hypnotics (84.6%) use was reported, while the use of amphetamines (59.7%), cocaine (67.5%), and opiates (58.2%) was reported to decrease overall. Conclusions: The global report on changes in the availability, use patterns, and complications of alcohol and drugs during the COVID-19 pandemic should be considered in making new policies and in developing mitigating measures and guidelines during the current pandemic (and probable future ones) in order to minimize risks to people with SUD. © Copyright © 2021 Farhoudian, Radfar, Mohaddes Ardabili, Rafei, Ebrahimi, Khojasteh Zonoozi, De Jong, Vahidi, Yunesian, Kouimtsidis, Arunogiri, Hansen, Brady, ISAM Global Survey Consortium (ISAM-GSC), Potenza, Baldacchino and Ekhtiari. |
addiction; behavioral addiction; COVID-19; global survey; illicit drug market; substance use disorder |
alcohol; cannabis; illicit drug; addiction medicine; adult; Article; coronavirus disease 2019; drug bioavailability; drug industry; female; gambling; health care personnel; health service; human; male; pandemic; pharmacist; prescription; questionnaire; substance use |
Frontiers Media S.A. |
16640640 |
|
|
Article |
Q1 |
1363 |
2668 |
|
|
232 |
Raharjanti N.W., Wiguna T., Purwadianto A., Soemantri D., Bardosono S., Poerwandari E.K., Mahajudin M.S., Ramadianto A.S., Alfonso C.A., Findyartini A., Nugrahadi N.R., Lazuardi M.Q., Subroto P.A.M., Saroso O.J.D.A., Levania M.K. |
57226872499;24367785700;18635479200;36640659100;21933841000;25628305200;57218600581;57226862690;7004331573;56543777300;57221694462;57226862998;57208444972;57226865761;57226868672; |
Clinical Reasoning in Forensic Psychiatry: Concepts, Processes, and Pitfalls |
2021 |
Frontiers in Psychiatry |
12 |
|
691377 |
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85113172545&doi=10.3389%2ffpsyt.2021.691377&partnerID=40&md5=a63e42686ad595c41e376dfb2ea2ffc6 |
Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Department of Forensic and Medicolegal, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Department of Medical Education, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Nutrition, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Faculty of Psychology, Universitas Indonesia, Jakarta, Indonesia; Department of Psychiatry, Airlangga University, Surabaya, Indonesia; Department of Psychiatry, Columbia University, New York, NY, United States |
Raharjanti, N.W., Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Wiguna, T., Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Purwadianto, A., Department of Forensic and Medicolegal, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Soemantri, D., Department of Medical Education, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Bardosono, S., Department of Nutrition, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Poerwandari, E.K., Faculty of Psychology, Universitas Indonesia, Jakarta, Indonesia; Mahajudin, M.S., Department of Psychiatry, Airlangga University, Surabaya, Indonesia; Ramadianto, A.S., Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Alfonso, C.A., Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Department of Psychiatry, Columbia University, New York, NY, United States; Findyartini, A., Department of Medical Education, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Nugrahadi, N.R., Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Lazuardi, M.Q., Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Subroto, P.A.M., Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Saroso, O.J.D.A., Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia; Levania, M.K., Department of Psychiatry, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas IndonesiaJakarta, Indonesia |
Forensic psychiatrists are often sought by the court of law to provide professional opinion on specific legal matters that have a major impact on the evaluee and possibly society at large. The quality of that opinion and recommendations rely on the quality of the analysis from the assessment results conducted by the psychiatrist. However, the definition and scope of a forensic psychiatric analysis is not clear. While existing literature on forensic psychiatric analysis generally includes organizing information, identifying relevant details, and formulating a set of forensic psychiatric opinions as components, there is no explicit and unified definition of these terms and process. This lack of clarity and guidelines may hinder forensic psychiatry from achieving its goal of providing objective information to the court or other relevant parties. Forensic psychiatric analysis exhibits numerous parallels to clinical reasoning in other fields of medicine. Therefore, this review aims to elaborate forensic psychiatric analysis through the lens of clinical reasoning, which has been developed by incorporating advances in cognitive sciences. We describe forensic psychiatric analysis through three prominent clinical reasoning theories: hypothetico-deductive model, illness script theory, and dual process theory. We expand those theories to elucidate how forensic psychiatrists use clinical reasoning not only to diagnose mental disorders, but also to determine mental capacities as requested by law. Cognitive biases are also described as potential threat to the accuracy of the assessment and analysis. Additionally, situated cognition theory helps elucidate how contextual factors influence risk of errors. Understanding the processes involved in forensic psychiatric analysis and their pitfalls can assist forensic psychiatrists to be aware of and try to mitigate their bias. Debiasing strategies that have been implemented in other fields of medicine to mitigate errors in clinical reasoning can be adapted for forensic psychiatry. This may also shape the training program of general psychiatrists and forensic psychiatrists alike. © Copyright © 2021 Raharjanti, Wiguna, Purwadianto, Soemantri, Bardosono, Poerwandari, Mahajudin, Ramadianto, Alfonso, Findyartini, Nugrahadi, Lazuardi, Subroto, Saroso and Levania. |
clinical reasoning; cognitive bias; debiasing strategy; dual process theory; forensic psychiatry; hypothetico-deductive model; illness-script theory; psychomedicolegal analysis |
clinical reasoning; cognitive bias; court; forensic psychiatry; human; mental capacity; practice guideline; psychiatrist; review; theoretical study; training |
Frontiers Media S.A. |
16640640 |
|
|
Review |
Q1 |
1363 |
2668 |
|
|
397 |
Siste K., Hanafi E., Sen L.T., Murtani B.J., Christian H., Limawan A.P., Siswidiani L.P., Adrian |
55644113100;56737010600;57219034101;57216652176;57209266195;57202712511;57219029296;57216932703; |
Implications of COVID-19 and Lockdown on Internet Addiction Among Adolescents: Data From a Developing Country |
2021 |
Frontiers in Psychiatry |
12 |
|
665675 |
|
|
|
6 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107077623&doi=10.3389%2ffpsyt.2021.665675&partnerID=40&md5=19567c64b9f1c1b25ae702d165f6737d |
Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
Siste, K., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Hanafi, E., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Sen, L.T., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Murtani, B.J., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Christian, H., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Limawan, A.P., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Siswidiani, L.P., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Adrian, Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
Introduction: Physical distancing policy during coronavirus disease 2019 (COVID-19) pandemic requires adolescents to spend most of their time at home, thus increasing Internet use duration. Limited social interaction with their peers may lead to loneliness and an increased risk of mental health among adolescents. This study aimed to assess the prevalence of Internet addiction (IA) among adolescents and analyze the influence of psychosocial factors toward the heightened risk of IA during the COVID-19 pandemic. Methods: An online survey comprising sociodemographic questionnaire, Internet Addiction Diagnostic Questionnaire (KDAI), Strengths and Difficulties Questionnaire (SDQ), and Pittsburgh Sleep Quality Index (PSQI) was distributed. Overall, a total of 2,932 adolescents (mean age, 17.38 ± 2.24 years old; female, 78.7%), originating from 33 of 34 provinces in Indonesia, completed the survey. Results: The point prevalence of IA among Indonesian adolescents during the COVID-19 outbreak was 19.3%. Increased Internet use duration, internalization, externalization, low prosocial behavior, and sleep disturbances were found as risk factors of IA, either directly or as mediating variables. Physical distancing, large-scale social restriction (PSBB), and health status were not correlated to IA. Discussion: Physical distancing was not established as a risk of IA. This could be due to other psychological factors such as internalization, externalization, prosocial, and sleep problems that had correlations to IA occurrence among adolescents in the COVID-19 pandemic. Sleep impairment might have resulted from the emotional and behavioral issues and directly contributed to IA development. Conclusion: The present study found the prevalence of IA among Indonesian adolescents to be higher than the adult during the COVID-19 pandemic. Several psychological measures were indicated to increase the risk of IA, while physical distancing did not elevate the risk. Thus, remote schooling is preferable in Indonesia along with proper parental supervision to minimize Internet use for entertainment purposes. © Copyright © 2021 Siste, Hanafi, Sen, Murtani, Christian, Limawan, Siswidiani and Adrian. |
adolescents; coronavirus disease 2019; Indonesia; internet addiction; lockdown; physical distancing; psychopathology; sleep quality |
adolescent; adolescent disease; age distribution; Article; behavior disorder; controlled study; coronavirus disease 2019; demography; developing country; emotional disorder; externalization (behavior); female; health status; health survey; human; Indonesia; Indonesian; internalization (behavior); internet addiction; Internet Addiction Diagnostic Questionnaire; major clinical study; male; national lockdown; pandemic; Pittsburgh Sleep Quality Index; prevalence; prosocial behavior; psychological aspect; questionnaire; risk assessment; sex ratio; sleep disorder; social aspect; social distancing; social psychology; strengths and difficulties questionnaire |
Frontiers Media S.A. |
16640640 |
|
|
Article |
Q1 |
1363 |
2668 |
|
|
426 |
Radfar S.R., De Jong C.A.J., Farhoudian A., Ebrahimi M., Rafei P., Vahidi M., Yunesian M., Kouimtsidis C., Arunogiri S., Massah O., Deylamizadeh A., Brady K.T., Busse A., Potenza M.N., Ekhtiari H., Baldacchino A.M., Abagiu A.O., Abouna F.D.N., Ahmed M.H., Al-ansari B., Mahmmoud Abu Al-khair F., Almaqbali M.H., Ambekar A., Ardabili H.M., Arya S., Lasebikan V.O., Ayasreh M.A., Basu D., Benmebarek Z., Bhad R., Blaise M., Bonnet N., Brasch J., Broers B., Butner J.L., Camilleri M., Campello G., Carra G., Celic I., Chalabianloo F., Chaturvedi A., de Jesús Eduardo Noyola Cherpitel J., Clark K.J., Cyders M.A., de Bernardis E., Derry J.E., Dhagudu N.K., Dolezalova P., Dom G., Dunlop A.J., Elhabiby M.M., Elkholy H., Essien N.F., Farah G.I., Ferri M., Floros G.D., Friedman C., Fuderanan C.H., Gerra G., Ghosh A., Gogia M., Grammatikopoulos I.A., Grandinetti P., Guirguis A., Gutnisky D., Haber P.S., Hassani-Abharian P., Hooshyari Z., Ibrahim I.I.M., Ieong H., Indradewi R.N., Iskandar S., Jain S., James S., Javadi S.M.H., Joe K.H., Jokubonis D., Jovanova A.T., Kamal R.M., Kantchelov A.I., Kathiresan P., Katzman G., Kawale P., Kern A.M., Kessler F.H.P., Kim S., Kimball A.M., Kljucevic Z., Siste K., Lev R., Lee H.K., Lengvenyte A., Lev-ran S., Mabelya G.S., Mahi M.A.E., Maphisa J., Maremmani I., Masferrer L., McCambridge O., McGovern G.G., Min A.K., Moghanibashi-Mansourieh A., Mora-Rios J., Mudalige I.U.K., Mukherjee D., Munira P.M., Myers B., Menon T N J., Narasimha V.L., Ndionuka N., Nejatisafa A., Niaz K., Nizami A.T., Nuijens J.H., Orsolini L., Oum V., Oyemade A.A., Palavra I.R., Pant S.B., Paredes J., Peyron E., Alberto Quirós R., Qurishi R., Rafiq N.U.Z., Rao R.R., Ratta-apha W., Raymond K., Reimer J., Renaldo E., Rezapour T., Robertson J.R., Roncero C., Roub F., Rubenstein E.J., Rupp C.I., Saenz E., Salehi M., Samartzis L., Sarubbo L.B., Segrec N., Shah B., Shen H., Shirasaka T., Shoptaw S., Sintango F.M., Sosa V.A., Subata E., Sztycberg N., Taghizadeh F., Teck J., Tjagvad C., Torrens M., Twala J.M., Vadivel R., Volpicelli J.R., Weijs J., Wintoniw S.M., Wittayanookulluk A., Wojnar M., Yasir S., Yitayih Y., Zhao M., Zonoozi A.K., ISAM-PPIG Global Survey Consortium |
36019651400;55394697400;25631625900;57218203004;57218199674;57203060812;14622058700;6602323007;55912287400;57044778200;57221410258;7101818468;57196510693;7006591634;26632924600;6603786612;55021572500;57221605725;57221411272;56996118200;57223918710;57221411355;35749590300;55658200400;35463222300;8344788700;57221410448;18833291700;57219202850;55789741800;6603894892;15135243700;57189041459;7003868723;56816710600;57221410155;56400851700;7003818736;24176502200;26026739900;54936844000;57221594973;57221410761;6504408224;55604104700;57221409824;57203836122;6603422138;12768470700;57219674374;26767656700;55086535500;57191041815;57221411550;8871569800;12768168000;57221411410;57210375852;55578764500;36833820900;57205763778;27367905800;55487378900;55496109900;57221411047;7004422180;54892046900;36607951600;57216708013;57193806115;57221410095;37004580200;57207211289;57216621884;57207842636;15062725000;57188646762;57221411023;57225330134;24468101500;57023935300;57221410517;55928375400;55031071400;57202970264;57221410531;35420584800;57203155640;55644113100;8913859800;8600274900;57189340754;23019092700;57221410613;57223919852;57200792839;7003948428;6507438528;56527137000;57221410507;57221411329;56059054800;6506077151;57214574855;57197364393;57221410358;7202684194;57202980793;56272241600;57221410263;55666521300;57194102646;12144358600;7004198198;55376767200;57217227990;16234058300;57225265059;36114863900;57221411223;57205355338;57223921125;55735687800;57221410341;57221411320;35604346900;56783754400;56000939600;57221410809;56968163500;57205640157;7003524112;57191926633;57221411128;7006106435;26656074800;56400278400;36633076300;57221409908;24476669600;57219874143;57216762422;7005625709;7003465287;57221409902;57221409982;56616079200;57221410011;55802145800;57212685292;57188537200;57202041764;57221411350;57219874702;57209053124;57221410085;57221410695;55151590700;6701757799;57221410275;57204013732;55185317400;57218205554; |
Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey |
2021 |
Frontiers in Psychiatry |
12 |
|
639393 |
|
|
|
14 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106509698&doi=10.3389%2ffpsyt.2021.639393&partnerID=40&md5=1fea38b85d8c747702486edae8c470b9 |
Department of Neuroscience and Addiction, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran; Integrated Substance Abuse Programs Department, University of California, Los Angeles, Los Angeles, CA, United States; Behavioral Science Institute Radboud University, Nijmegen, Netherlands; Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Materials and Energy Research Center, Tehran, Iran; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Department of Psychology, Faculty of Psychology and Education, University of Tehran, Tehran, Iran; School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Surrey and Borders Partnership, NHS Foundation Trust, Leatherhead, United Kingdom; Turning Point, Eastern Health, Box Hill, VIC, Australia; Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; Rebirth Charity Society NGO, Tehran, Iran; Medical University of South Carolina, Charleston, SC, United States; Drug Prevention and Health Branch, Division for Operations, United States; Connecticut Council on Problem Gambling, Connecticut Mental Health Center, Yale School of Medicine, New Haven, CT, United States; Laureate Institute for Brain Research, Tulsa, OK, United States; School of Medicine, University of St Andrews, St Andrews, United Kingdom; Office on Drugs and Crime, Vienna, Austria; Prof. Dr. Matei Bals- Arena OMT Department, National Institute for Infectious Diseases, Bucharest, Romania; Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; Alamal psychiatric hospital, Dubai, United Arab Emirates; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Al Ahliyya Amman University, Amman, Jordan; Ministry of Health, Muscat, Oman; Department of Psychiatry and National Drug Dependence Treatment Center (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Faculty of Medicine, Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran; State Drug Dependence Treatment Center, Institute of Mental Health, Pt BDS University of Health Sciences, Rohtak, India; Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria; Addiction medicine clinic, Amman, Jordan; Department of Psychiatry, Drug De-addiction & Treatment Center, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Addiction medicine clinic, Mila, Algeria; Center medical Marmottan, Paris, France; Réseau de Prévention des Addictions (RESPADD), Paris, France; Department of Psychiatry and Behavioral Neurosciences, Michael DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Geneva University Hospitals, Geneva, Switzerland; CUNY School of Medicine, New York, NY, United States; AÄ¡enzija Sedqa, Santa Venera, Malta; United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Department of Medicine and Surgery, University Milan-Bicocca, Milan, Italy; University Psychiatric Hospital Vrapce, Zagreb, Croatia; Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway; Department of Biochemistry, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal, India; Addiction medicine clinic, Mexico City, Mexico; Addiction Crisis Solutions, Louisville, KY, United States; Department of Psychology, Indiana University Purdue University - Indianapolis, Indianapolis, IN, United States; SerT Lentini, ASP Siracusa, Syracuse, Italy; Serenity Vista Addiction Treatment Center, Jaramillo, Panama; Department of Psychiatry, ESIC Medical College, Hyderabad, India; National Institute of Mental Health, Klecany, Czech Republic; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Antwerp, Belgium; Drug & Alcohol Clinical Services, Hunter New England Local Health District, New Lambton, NSW, Australia; Ain Shams University, Cairo, Egypt; Department of Neurology and Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Center for Research and Information on Substance Abuse, Jos, Nigeria; Addiction Medicine Clinic, Damascus, Syrian Arab Republic; European Monitoring Center for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal; 2nd Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece; Brown University and Lifespan Health System, Providence, RI, United States; Fuderanan Mental Health Clinic, Manila, Philippines; Georgian Harm Reduction Network, Tbilisi, Georgia; Organization Against Drugs, Primary Care Health Center, Veria, Greece; Addictions Services (Ser.D.), Department of Territorial Assistance, ASL Teramo, Teramo, Italy; Swansea University Medical School, Institute of Life Sciences 2, Sketty, United Kingdom; Hospital Borda, Universidad de Buenos Aires, Buenos Aires, Argentina; University of Sydney, Sydney, NSW, Australia; Institutes for Cognitive Science Studies (IRICSS), Brain and Cognition Clinic, Tehran, Iran; Tehran University of Medical Sciences, Tehran, Iran; Department of Anesthesiology, Yale University, New Haven, CT, United States; Drugs Rehabilitation Center, National Narcotics Board of Indonesia, East Jakarta, Indonesia; Department of Psychiatry, Universitas Padjadjaran, Bandung, Indonesia; Department of Psychiatry, Heritage Institute of Medical Sciences (HIMS), Varanasi, India; Univeristi Malaysia Sabah, Sabah, Malaysia; Department of Social Work, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran; National Center for Mental Health of Korea, Seoul, South Korea; Republican Center for Addictive Disorders, Vilnius, Lithuania; Addiction medicine clinic, Skopje, North Macedonia; Naufar Institute, Doha, Qatar; The Kantchelov Clinic, Sofia, Bulgaria; Mount Sinai Medical Center, New York, NY, United States; African Institute for Development Policy, Lilongwe, Malawi; Sobriety Centers of New Hampshire, Antrim, NH, United States; Federal University of Rio Grande do Sul, Porto Alegre, Brazil; Department of Neuropsychiatry, Pusan National University Yangsan Hospital, Yangsan, South Korea; Chatham House, Washington, United States; Institute for Public Health of Split-Dalmatia County, Split, Croatia; Faculty of Medicine, Universitas Indonesia-Ciptomangunkusumo Hospital, Jakarta, Indonesia; Scripps Mercy Hospital, San Diego, CA, United States; Department of Psychiatry, The Catholic University of Korea, Seoul, South Korea; Faculty of Medicine, Institute of Clinical Medicine, Psychiatric Clinic, Vilnius University, Vilnius, Lithuania; Tel Aviv University, Tel Aviv, Israel; Israel Center on Addiction, Netanya, Israel; Community Health Work, Dar es Salaam, Tanzania; Hayat Center for Treatment and Psycho-social Rehabilitation, Khartoum, Sudan; University of Botswana, Gaborone, Botswana; V.P. Dole, Dual Disorder Unit, Santa Chiara University Hospital, University of Pisa, Pisa, Italy; CAS Girona, Department of Psychology, University of Girona, Girona, Spain; Community addiction team, Southern Health and Social Care Trust, Craigavon, United Kingdom; Priority Medical Clinic, Dublin, Ireland; Save the Children International, Yangon, Myanmar; Dirección de Investigaciones Epidemiológicas y Sociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico; Department of Psychiatry, Faculty of Medicine, Sir John Kotelawala Defense University, Colombo, Sri Lanka; Center for Addiction Medicine, NIMHANS, Bangalore, India; Kleopatra Kodric, Irena Nisic, Ljubljana, Slovenia; Alcohol Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa; NIMHANS, Bangalore, India; Department of Psychiatry, Center for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, India; Federal Neuropsychiatric Hospital, Calabar, Nigeria; Department of Psychiatry, Psychosomatic Research Center, Tehran University of Medical Sciences, Tehran, Iran; Institute of Psychiatry, WHO Collaborating Center for Mental Health, Rawalpindi, Pakistan; Brijder Addiction Care, Zaandam, Netherlands; Department of Clinical Neurosciences/DIMSC, Unit of Clinical Psychiatry, School of Medicine, Polytechnic University of Marche, Ancona, Italy; Koh Kong Provincial Hospital, Phoumin, Cambodia; Kaiser Permanente, Oakland, CA, United States; Psychiatric hospital Sveti Ivan, Zagreb, Croatia; Department of Psychiatry and mental health, Institute of Medicine, Tribhuvan University, Kirtipur, Nepal; Universidad de El Salvador, San Salvador, El Salvador; AddiPsy, Lyon, France; Addiction medicine clinic, San José, Costa Rica; Novadic-Kentron Addiction Care Network, Vught, Netherlands; Phoenix Foundation for Research and Development, Lahore, Pakistan; Barwon Health, Geelong, VIC, Australia; Faculty of Medicine Siriraj Hospital, Mahidol University, Salaya, Thailand; University of the Sunshine Coast (USC), QueenslandQLD, Australia; Center for Interdisciplinary Addiction Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Drugs Rehabilitation Center, National Narcotics Board of Indonesia, East Jakarta, Indonesia; Department of Cognitive Psychology, Institute for Cognitive Science Studies, Tehran, Iran; Usher Institute, University of Edinburgh, Edinburgh, United Kingdom; Psychiatry Service, University of Salamanca Health Care Complex, School of Medicine, University of Salamanca, Salamanca, Spain; PGIMER, Chandigarh, India; Street Health Center, Kingston, ON, Canada; Department of Psychiatry, Psychotherapy, and Psychosomatics, Medical University Innsbruck, Innsbruck, Austria; Department of Neurosciences and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Medical School, University of Cyprus, Cyprus; Clínica Psiquiátrica de la Facultad de Medicina, Uruguay; Center for Treatment of Drug addiction, University Psychiatric Clinic, Ljubljana, Slovenia; Department of Psychiatry, Patan Academy of Health Sciences, School of Medicine, Lagankhel, Nepal; Department of Psychiatry, Second Xiangya Hospital, Central South University, Changsha, China; Department of Psychiatry, Teine Keijinkai Medical Center, Sapporo, Hokkaido, Japan; Department of Family Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; Health Professions Councils of Namibia, Windhoek, Namibia; Addiction medicine clinic, Montevideo, Uruguay; Republican Center for Addictive Disorders, Vilnius, Lithuania; Asociasion Programa Andres Argentina, Santa Fe, Argentina; Mazandaran University of Medical Sciences, Mazandaran, Iran; MRC/CSO SPHSU, University of Glasgow, Glasgow, United Kingdom; Gladsaxe Substance Use Disorder Treatment Center, Gladsaxe, Denmark; Institut de Neuropsiquiatria i Addiccions, IMIM-Hospital del Mar, Medical Research, Barcelona, Spain; NACADA, Nairobi, Kenya; Waikato District Health Board (WDHB) Hamilton, Hamilton, New Zealand; Institute of Addiction Medicine, Plymouth Meeting, PA, United States; Jellinek, Amsterdam, Netherlands; Addictions Foundation of Manitoba, Manitoba, Canada; Thanyarak Chiangmai hospital, Khilek, Thailand; Medical University of Warsaw, Warsaw, Poland; Jimma University, Jimma, Ethiopia; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran |
Radfar, S.R., Department of Neuroscience and Addiction, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran, Integrated Substance Abuse Programs Department, University of California, Los Angeles, Los Angeles, CA, United States; De Jong, C.A.J., Behavioral Science Institute Radboud University, Nijmegen, Netherlands; Farhoudian, A., Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Ebrahimi, M., Materials and Energy Research Center, Tehran, Iran, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Rafei, P., Department of Psychology, Faculty of Psychology and Education, University of Tehran, Tehran, Iran; Vahidi, M., Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Yunesian, M., School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Kouimtsidis, C., Surrey and Borders Partnership, NHS Foundation Trust, Leatherhead, United Kingdom; Arunogiri, S., Turning Point, Eastern Health, Box Hill, VIC, Australia; Massah, O., Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; Deylamizadeh, A., Rebirth Charity Society NGO, Tehran, Iran; Brady, K.T., Medical University of South Carolina, Charleston, SC, United States; Busse, A., Drug Prevention and Health Branch, Division for Operations, United States, Office on Drugs and Crime, Vienna, Austria; Potenza, M.N., Connecticut Council on Problem Gambling, Connecticut Mental Health Center, Yale School of Medicine, New Haven, CT, United States; Ekhtiari, H., Laureate Institute for Brain Research, Tulsa, OK, United States; Baldacchino, A.M., School of Medicine, University of St Andrews, St Andrews, United Kingdom; Abagiu, A.O., Prof. Dr. Matei Bals- Arena OMT Department, National Institute for Infectious Diseases, Bucharest, Romania; Abouna, F.D.N., Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; Ahmed, M.H., Alamal psychiatric hospital, Dubai, United Arab Emirates; Al-ansari, B., Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Mahmmoud Abu Al-khair, F., Al Ahliyya Amman University, Amman, Jordan; Almaqbali, M.H., Ministry of Health, Muscat, Oman; Ambekar, A., Department of Psychiatry and National Drug Dependence Treatment Center (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Ardabili, H.M., Faculty of Medicine, Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran; Arya, S., State Drug Dependence Treatment Center, Institute of Mental Health, Pt BDS University of Health Sciences, Rohtak, India; Lasebikan, V.O., Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria; Ayasreh, M.A., Addiction medicine clinic, Amman, Jordan; Basu, D., Department of Psychiatry, Drug De-addiction & Treatment Center, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Benmebarek, Z., Addiction medicine clinic, Mila, Algeria; Bhad, R., Department of Psychiatry and National Drug Dependence Treatment Center (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Blaise, M., Center medical Marmottan, Paris, France; Bonnet, N., Réseau de Prévention des Addictions (RESPADD), Paris, France; Brasch, J., Department of Psychiatry and Behavioral Neurosciences, Michael DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Broers, B., Geneva University Hospitals, Geneva, Switzerland; Butner, J.L., CUNY School of Medicine, New York, NY, United States; Camilleri, M., AÄ¡enzija Sedqa, Santa Venera, Malta; Campello, G., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Carra, G., Department of Medicine and Surgery, University Milan-Bicocca, Milan, Italy; Celic, I., University Psychiatric Hospital Vrapce, Zagreb, Croatia; Chalabianloo, F., Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway; Chaturvedi, A., Department of Biochemistry, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal, India; de Jesús Eduardo Noyola Cherpitel, J., Addiction medicine clinic, Mexico City, Mexico; Clark, K.J., Addiction Crisis Solutions, Louisville, KY, United States; Cyders, M.A., Department of Psychology, Indiana University Purdue University - Indianapolis, Indianapolis, IN, United States; de Bernardis, E., SerT Lentini, ASP Siracusa, Syracuse, Italy; Derry, J.E., Serenity Vista Addiction Treatment Center, Jaramillo, Panama; Dhagudu, N.K., Department of Psychiatry, ESIC Medical College, Hyderabad, India; Dolezalova, P., National Institute of Mental Health, Klecany, Czech Republic; Dom, G., Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Antwerp, Belgium; Dunlop, A.J., Drug & Alcohol Clinical Services, Hunter New England Local Health District, New Lambton, NSW, Australia; Elhabiby, M.M., Ain Shams University, Cairo, Egypt; Elkholy, H., Department of Neurology and Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Essien, N.F., Center for Research and Information on Substance Abuse, Jos, Nigeria; Farah, G.I., Addiction Medicine Clinic, Damascus, Syrian Arab Republic; Ferri, M., European Monitoring Center for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal; Floros, G.D., 2nd Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece; Friedman, C., Brown University and Lifespan Health System, Providence, RI, United States; Fuderanan, C.H., Fuderanan Mental Health Clinic, Manila, Philippines; Gerra, G., Geneva University Hospitals, Geneva, Switzerland; Ghosh, A., Department of Psychiatry, Drug De-addiction & Treatment Center, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Gogia, M., Georgian Harm Reduction Network, Tbilisi, Georgia; Grammatikopoulos, I.A., Organization Against Drugs, Primary Care Health Center, Veria, Greece; Grandinetti, P., Addictions Services (Ser.D.), Department of Territorial Assistance, ASL Teramo, Teramo, Italy; Guirguis, A., Swansea University Medical School, Institute of Life Sciences 2, Sketty, United Kingdom; Gutnisky, D., Hospital Borda, Universidad de Buenos Aires, Buenos Aires, Argentina; Haber, P.S., University of Sydney, Sydney, NSW, Australia; Hassani-Abharian, P., Institutes for Cognitive Science Studies (IRICSS), Brain and Cognition Clinic, Tehran, Iran; Hooshyari, Z., Tehran University of Medical Sciences, Tehran, Iran; Ibrahim, I.I.M., Ain Shams University, Cairo, Egypt; Ieong, H., Department of Anesthesiology, Yale University, New Haven, CT, United States; Indradewi, R.N., Drugs Rehabilitation Center, National Narcotics Board of Indonesia, East Jakarta, Indonesia; Iskandar, S., Department of Psychiatry, Universitas Padjadjaran, Bandung, Indonesia; Jain, S., Department of Psychiatry, Heritage Institute of Medical Sciences (HIMS), Varanasi, India; James, S., Univeristi Malaysia Sabah, Sabah, Malaysia; Javadi, S.M.H., Department of Social Work, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran; Joe, K.H., National Center for Mental Health of Korea, Seoul, South Korea; Jokubonis, D., Republican Center for Addictive Disorders, Vilnius, Lithuania; Jovanova, A.T., Addiction medicine clinic, Skopje, North Macedonia; Kamal, R.M., Naufar Institute, Doha, Qatar; Kantchelov, A.I., The Kantchelov Clinic, Sofia, Bulgaria; Kathiresan, P., Department of Psychiatry and National Drug Dependence Treatment Center (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Katzman, G., Mount Sinai Medical Center, New York, NY, United States; Kawale, P., African Institute for Development Policy, Lilongwe, Malawi; Kern, A.M., Sobriety Centers of New Hampshire, Antrim, NH, United States; Kessler, F.H.P., Federal University of Rio Grande do Sul, Porto Alegre, Brazil; Kim, S., Department of Neuropsychiatry, Pusan National University Yangsan Hospital, Yangsan, South Korea; Kimball, A.M., Chatham House, Washington, United States; Kljucevic, Z., Institute for Public Health of Split-Dalmatia County, Split, Croatia; Siste, K., Faculty of Medicine, Universitas Indonesia-Ciptomangunkusumo Hospital, Jakarta, Indonesia; Lev, R., Scripps Mercy Hospital, San Diego, CA, United States; Lee, H.K., Department of Psychiatry, The Catholic University of Korea, Seoul, South Korea; Lengvenyte, A., Faculty of Medicine, Institute of Clinical Medicine, Psychiatric Clinic, Vilnius University, Vilnius, Lithuania; Lev-ran, S., Tel Aviv University, Tel Aviv, Israel, Israel Center on Addiction, Netanya, Israel; Mabelya, G.S., Community Health Work, Dar es Salaam, Tanzania; Mahi, M.A.E., Hayat Center for Treatment and Psycho-social Rehabilitation, Khartoum, Sudan; Maphisa, J., University of Botswana, Gaborone, Botswana; Maremmani, I., V.P. Dole, Dual Disorder Unit, Santa Chiara University Hospital, University of Pisa, Pisa, Italy; Masferrer, L., CAS Girona, Department of Psychology, University of Girona, Girona, Spain; McCambridge, O., Community addiction team, Southern Health and Social Care Trust, Craigavon, United Kingdom; McGovern, G.G., Priority Medical Clinic, Dublin, Ireland; Min, A.K., Save the Children International, Yangon, Myanmar; Moghanibashi-Mansourieh, A., National Center for Mental Health of Korea, Seoul, South Korea; Mora-Rios, J., Dirección de Investigaciones Epidemiológicas y Sociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico; Mudalige, I.U.K., Department of Psychiatry, Faculty of Medicine, Sir John Kotelawala Defense University, Colombo, Sri Lanka; Mukherjee, D., Center for Addiction Medicine, NIMHANS, Bangalore, India; Munira, P.M., Kleopatra Kodric, Irena Nisic, Ljubljana, Slovenia; Myers, B., Alcohol Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa; Menon T N, J., NIMHANS, Bangalore, India; Narasimha, V.L., Department of Psychiatry, Center for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, India; Ndionuka, N., Federal Neuropsychiatric Hospital, Calabar, Nigeria; Nejatisafa, A., Department of Psychiatry, Psychosomatic Research Center, Tehran University of Medical Sciences, Tehran, Iran; Niaz, K., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Nizami, A.T., Institute of Psychiatry, WHO Collaborating Center for Mental Health, Rawalpindi, Pakistan; Nuijens, J.H., Brijder Addiction Care, Zaandam, Netherlands; Orsolini, L., Department of Clinical Neurosciences/DIMSC, Unit of Clinical Psychiatry, School of Medicine, Polytechnic University of Marche, Ancona, Italy; Oum, V., Koh Kong Provincial Hospital, Phoumin, Cambodia; Oyemade, A.A., Kaiser Permanente, Oakland, CA, United States; Palavra, I.R., Psychiatric hospital Sveti Ivan, Zagreb, Croatia; Pant, S.B., Department of Psychiatry and mental health, Institute of Medicine, Tribhuvan University, Kirtipur, Nepal; Paredes, J., Universidad de El Salvador, San Salvador, El Salvador; Peyron, E., AddiPsy, Lyon, France; Alberto Quirós, R., Addiction medicine clinic, San José, Costa Rica; Qurishi, R., Novadic-Kentron Addiction Care Network, Vught, Netherlands; Rafiq, N.U.Z., Phoenix Foundation for Research and Development, Lahore, Pakistan; Rao, R.R., Barwon Health, Geelong, VIC, Australia; Ratta-apha, W., Faculty of Medicine Siriraj Hospital, Mahidol University, Salaya, Thailand; Raymond, K., University of the Sunshine Coast (USC), QueenslandQLD, Australia; Reimer, J., Center for Interdisciplinary Addiction Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Renaldo, E., Drugs Rehabilitation Center, National Narcotics Board of Indonesia, East Jakarta, Indonesia; Rezapour, T., Department of Cognitive Psychology, Institute for Cognitive Science Studies, Tehran, Iran; Robertson, J.R., Usher Institute, University of Edinburgh, Edinburgh, United Kingdom; Roncero, C., Psychiatry Service, University of Salamanca Health Care Complex, School of Medicine, University of Salamanca, Salamanca, Spain; Roub, F., PGIMER, Chandigarh, India; Rubenstein, E.J., Street Health Center, Kingston, ON, Canada; Rupp, C.I., Department of Psychiatry, Psychotherapy, and Psychosomatics, Medical University Innsbruck, Innsbruck, Austria; Saenz, E., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Salehi, M., Department of Neurosciences and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Samartzis, L., Medical School, University of Cyprus, Cyprus; Sarubbo, L.B., Clínica Psiquiátrica de la Facultad de Medicina, Uruguay; Segrec, N., Center for Treatment of Drug addiction, University Psychiatric Clinic, Ljubljana, Slovenia; Shah, B., Department of Psychiatry, Patan Academy of Health Sciences, School of Medicine, Lagankhel, Nepal; Shen, H., Department of Psychiatry, Second Xiangya Hospital, Central South University, Changsha, China; Shirasaka, T., Department of Psychiatry, Teine Keijinkai Medical Center, Sapporo, Hokkaido, Japan; Shoptaw, S., Department of Family Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; Sintango, F.M., Health Professions Councils of Namibia, Windhoek, Namibia; Sosa, V.A., Addiction medicine clinic, Montevideo, Uruguay; Subata, E., Republican Center for Addictive Disorders, Vilnius, Lithuania; Sztycberg, N., Asociasion Programa Andres Argentina, Santa Fe, Argentina; Taghizadeh, F., Mazandaran University of Medical Sciences, Mazandaran, Iran; Teck, J., MRC/CSO SPHSU, University of Glasgow, Glasgow, United Kingdom; Tjagvad, C., Gladsaxe Substance Use Disorder Treatment Center, Gladsaxe, Denmark; Torrens, M., Institut de Neuropsiquiatria i Addiccions, IMIM-Hospital del Mar, Medical Research, Barcelona, Spain; Twala, J.M., NACADA, Nairobi, Kenya; Vadivel, R., Waikato District Health Board (WDHB) Hamilton, Hamilton, New Zealand; Volpicelli, J.R., Institute of Addiction Medicine, Plymouth Meeting, PA, United States; Weijs, J., Jellinek, Amsterdam, Netherlands; Wintoniw, S.M., Addictions Foundation of Manitoba, Manitoba, Canada; Wittayanookulluk, A., Thanyarak Chiangmai hospital, Khilek, Thailand; Wojnar, M., Medical University of Warsaw, Warsaw, Poland; Yasir, S., Institute of Psychiatry, WHO Collaborating Center for Mental Health, Rawalpindi, Pakistan; Yitayih, Y., Jimma University, Jimma, Ethiopia; Zhao, M., Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Zonoozi, A.K., Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; ISAM-PPIG Global Survey Consortium |
Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees. © Copyright © 2021 Radfar, De Jong, Farhoudian, Ebrahimi, Rafei, Vahidi, Yunesian, Kouimtsidis, Arunogiri, Massah, Deylamizadeh, Brady, Busse, ISAM-PPIG Global Survey Consortium, Potenza, Ekhtiari and Baldacchino. |
addiction services; COVID-19 pandemic; drug policy; harm reduction; opioid agonist treatment; public health; substance use disorder |
buprenorphine; methadone; adult; Article; commercial phenomena; controlled study; coronavirus disease 2019; drug dependence; drug dependence treatment; drug shortage; female; geographic distribution; harm reduction; health care access; health care management; health care personnel; health care policy; health care system; health program; high income country; human; immigrant; low income country; male; mental health care; mental health service; middle aged; middle income country; pandemic; questionnaire; refugee |
Frontiers Media S.A. |
16640640 |
|
|
Article |
Q1 |
1363 |
2668 |
|
|